HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021

Publisher Name :
Date: 07-Mar-2017
No. of pages: 137
Inquire Before Buying

The HIV diagnosis market is projected to reach USD 3.88 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of10.5% from 2016 to 2021. The global HIV diagnosis marketis segmented based on product, test type, end user, and region. On the basis of product, the market is segmented into consumables (assays, kits, reagents, and other consumables), instruments, and software &services. The consumable segment is expected to register the highest CAGR during the forecast period. The frequent and repetitive purchase of consumables by laboratories and hospitals, growing prevalence of HIV/AIDS, and increasing initiatives from governments to fight HIV/AIDS are some of the major factors driving the consumables market.

On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests.The antibody tests segment is expected to account for the largest share of the HIV diagnosis market in 2016.These tests are widely adopted to screening and confirmation of HIV antibodies. Moreover, increasing prevalence of HIV/AIDS, increasing awareness about HIV, increasing blood donations and transfusions, and advancements in technology are expected to drive the growth of this market.

On the basis of end user, the HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of HIV diagnosis market in 2016. Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment.

Geographically, North America dominates the global HIV diagnosis market. The government initiatives and funding in order to increase HIV diagnosis procedures and create awareness amongst the pollution and increasing number of blood transfusions are increasing the demand for HIV diagnosis products in North America.

The major factors contributing to the growth of the global HIV diagnosis market include the increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing government initiatives. On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the HIV diagnosis market.

The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).

Research Coverage

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios of the top players in the HIV diagnosis market. The report analyses the HIV diagnosis market by product, test type, end user, and region.

  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the HIV diagnosis market

  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the HIV diagnosis market

  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for HIV diagnosis across geographies

  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the HIV diagnosis market.

HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 HIV Diagnosis: Market Overview
4.2 Geographic Analysis: HIV Diagnosis Market, By Test Type (2016)
4.3 Geographic Snapshot of the Market
4.4 Life Cycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Growing Worldwide Prevalence of HIV/Aids
5.1.1.2 Increasing Number of Blood Transfusions and Blood Donations
5.1.1.3 Benefits Offered By Point-Of-Care Instruments & Kits
5.1.1.4 Increasing Government Initiatives
5.1.2 Restraints
5.1.2.1 High Cost of Nat
5.1.2.2 Lack of Mandates for Nat in Developing Countries
5.1.3 Opportunity
5.1.3.1 Emerging Economies Offer Lucrative Growth Opportunities for HIV Diagnosis
5.1.4 Trend
5.1.4.1 Increase in Use of Home Access Kits and Instruments

6 HIV Diagnosis Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Assays and Kits & Reagents
6.2.2 Other Consumables
6.3 Instruments
6.4 Software & Services

7 HIV Diagnosis Market, By Test Type
7.1 Introduction
7.2 Antibody Tests
7.2.1 HIV-1 Screening Tests
7.2.1.1 Elisa
7.2.1.2 Rapid Tests
7.2.1.3 Home Access Dried Blood Spots
7.2.2 HIV-1 Antibody Confirmatory Tests
7.2.2.1 Western Blot Tests
7.2.2.2 Indirect Immunofluorescence Assays (IFA)
7.2.2.3 Line Immunoassays
7.2.2.4 Radio-Immunoprecipitation Assays
7.2.3 HIV-2 & Group O Diagnostic Tests
7.3 Viral Load Tests
7.4 CD4 Tests
7.5 Tests for Early Infant Diagnosis
7.6 Tests for Viral Identification

8 HIV Diagnosis Market, By End User
8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Hospitals
8.4 Blood Banks
8.5 Home Care Settings
8.6 Other End Users

9 HIV Diagnosis Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia (RoA)
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Introduction
10.2 Strategic Overview
10.3 Market Share Analysis
10.4 Competitive Situation and Trends
10.4.1 Product Launches
10.4.2 Agreements, Partnerships & Collaborations
10.4.3 Expansions
10.4.4 Other Developments

11 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Siemens Healthineers (A Division of Siemens AG)
11.3 Roche Diagnostics (Division of Hoffman La Roche Ltd.)
11.4 Abbott Laboratories
11.5 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
11.6 Thermo-Fisher Scientific Inc.
11.7 Merck KGaA
11.8 Becton, Dickinson & Company
11.9 Hologic Inc.
11.10 Alere Inc.
11.11 Bio-Rad Laboratories

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables

Table 1 Global HIV Prevalence, 2015
Table 2 Global HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 3 Global HIV Diagnosis Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 4 Global HIV Diagnosis Market Size for Consumables, By Region, 2014–2021 (USD Million)
Table 5 Global HIV Diagnosis Market Size for Assays and Kits & Reagents, By Region, 2014–2021 (USD Million)
Table 6 Global Market Size for Other Consumables, By Region, 2014–2021 (USD Million)
Table 7 Global Market Size for Instruments, By Region, 2014–2021 (USD Million)
Table 8 Global Market Size for Software & Services, By Region, 2014–2021 (USD Million)
Table 9 Market Size, By Type of Test, 2014–2021 (USD Million)
Table 10 Market Size for Antibody Tests, By Type, 2014–2021 (USD Million)
Table 11 Market Size for Antibody Tests, By Region, 2014–2021 (USD Million)
Table 12 HIV-1 Screening Tests Market Size, By Type, 2014–2021 (USD Million)
Table 13 HIV-1 Screening Tests Market Size, By Region, 2014–2021 (USD Million)
Table 14 HIV-1 Screening Tests Market Size for Elisa, By Region, 2014–2021 (USD Million)
Table 15 HIV-1 Screening Tests Market Size for Rapid Tests, By Region, 2014–2021 (USD Million)
Table 16 HIV-1 Screening Tests Market Size for Home Access Dried Blood Spots, By Region, 2014–2021 (USD Million)
Table 17 HIV-1 Antibody Confirmatory Tests Market Size, By Type, 2014–2021 (USD Million)
Table 18 HIV-1 Antibody Confirmatory Tests Market Size, By Region, 2014–2021 (USD Million)
Table 19 HIV-1 Antibody Confirmatory Tests Market Size for Western Blot Tests, By Region, 2014–2021 (USD Million)
Table 20 HIV-1 Antibody Confirmatory Tests Market Size for Indirect IFA, By Region, 2014–2021 (USD Million)
Table 21 HIV-1 Antibody Confirmatory Tests Market Size for Line Immunoassays, By Region, 2014–2021 (USD Million)
Table 22 HIV-1 Antibody Confirmatory Tests Market Size for Radio-Immunoprecipitation Assays, By Region, 2014–2021 (USD Million)
Table 23 HIV-2 & Group O Diagnostic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 24 Market Size for Viral Load Tests, By Region, 2014–2021 (USD Million)
Table 25 Market Size for CD4 Tests, By Region, 2014–2021 (USD Million)
Table 26 Market Size for Tests for Early Infant Diagnosis, By Region, 2014–2021 (USD Million)
Table 27 Market Size for Tests for Viral Identification, By Region, 2014–2021 (USD Million)
Table 28 Market Size, By End User, 2014–2021 (USD Million)
Table 29 Global Market Size for Diagnostic Laboratories, By Region, 2014–2021 (USD Million)
Table 30 Global Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 31 Global Market Size for Blood Banks, By Region, 2014–2021 (USD Million)
Table 32 Global Market Size for Home Care Settings, By Region, 2014–2021 (USD Million)
Table 33 Global Market Size for Other End Users, By Region, 2014–2021 (USD Million
Table 34 Global Market Size, By Region, 2014–2021 (USD Million)
Table 35 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 36 North America: Market Size, By Test Type, 2014–2021 (USD Million)
Table 37 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 38 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 39 U.S.: Market Size, By Test Type, 2014–2021 (USD Million)
Table 40 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 41 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 42 Canada: Market Size, By Test Type, 2014–2021 (USD Million)
Table 43 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 44 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 45 Number of HIV Tests in Europe, By Country, 2014
Table 46 Europe: Market Size, By Test Type, 2014–2021 (USD Million)
Table 47 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 48 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 49 Asia: Market Size, By Country, 2014–2021 (USD Million)
Table 50 Asia: Market Size, By Test Type, 2014–2021 (USD Million)
Table 51 Asia: Market Size, By Product, 2014–2021 (USD Million)
Table 52 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 53 China: Market Size, By Test Type, 2014–2021 (USD Million)
Table 54 China: Market Size, By Product, 2014–2021 (USD Million)
Table 55 China: Market Size, By End User, 2014–2021 (USD Million)
Table 56 Japan: Market Size, By Test Type, 2014–2021 (USD Million)
Table 57 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 58 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 59 India: Market Size, By Test Type, 2014–2021 (USD Million)
Table 60 India: Market Size, By Product, 2014–2021 (USD Million)
Table 61 India: Market Size, By End User, 2014–2021 (USD Million)
Table 62 RoA: Market Size, By Test Type, 2014–2021 (USD Million)
Table 63 RoA: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 64 RoA: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 65 RoW: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 66 RoW: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 67 RoW: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 68 Growth Strategy Matrix, 2014–2016
Table 69 Product Launches, 2014–2016
Table 70 Agreements, Partnerships, & Collaborations, 2014–2016
Table 71 Expansions, 2014–2016
Table 72 Other Developments, 2014–2016

List of Figures

Figure 1 Global HIV Diagnosis Market Segmentation
Figure 2 HIV Diagnosis Market: Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 HIV Diagnosis Market: Bottom-Up Approach
Figure 5 HIV Diagnosis Market: Top-Down Approach
Figure 6 HIV Diagnosis Market: Data Triangulation Methodology
Figure 7 Global HIV Diagnosis Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Global HIV Diagnosis Market Size, By Test Type, 2016 vs 2021 (USD Million)
Figure 9 Global HIV Diagnosis Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographical Snapshot of the HIV Diagnosis Market
Figure 11 Global HIV Diagnosis Market to Witness Moderate Growth During the Forecast Period
Figure 12 Antibody Tests Segment Commanded the Largest Share of the Global HIV Diagnosis Market in 2016
Figure 13 Asia Projected to Register the Highest CAGR During the Forecast Period
Figure 14 Asian Market Showcases Lucrative Growth Opportunities
Figure 15 HIV Diagnosis Market: Drivers, Restraints, Opportunities, and Trends
Figure 16 HIV Diagnosis Market Segmentation, By Product
Figure 17 Consumables Were the Largest Product Segment in the HIV Diagnosis Market in 2016
Figure 18 Assays and Kits & Reagents Were the Largest Product Segment in 2016
Figure 19 HIV Diagnosis Market Segmentation, By Test Type
Figure 20 Antibody Tests Were the Largest Test Segment in the HIV Diagnosis Market in 2016
Figure 21 HIV-1 Screening Tests Dominated the HIV Diagnosis Market for Antibody Tests in 2016
Figure 22 Elisa Was the Largest HIV-1 Screening Tests Segment in 2016
Figure 23 Western Blot Tests Were the Largest Segment in the HIV-1 Antibody Confirmatory Tests Market in 2016
Figure 24 Diagnostic Laboratories Commanded the Largest Market Share in 2016
Figure 25 Geographic Snapshot: Emerging Markets in Asia Offer Significant Growth Opportunities in the HIV Diagnosis Market
Figure 26 HIV Diagnosis Market in Asia to Register the Highest CAGR During Forecast Period
Figure 27 North America: HIV Diagnosis Market Snapshot
Figure 28 U.S. to Dominate the North American HIV Diagnosis Market During the Forecast Period
Figure 29 Antibody Tests Dominated the North American HIV Diagnosis Market, By Test Type, in 2016
Figure 30 Viral Load Tests Segment to Register the Highest CAGR in the U.S. HIV Diagnosis Market
Figure 31 Antibody Tests Form the Largest Segment in the Canadian HIV Diagnosis Market in 2016
Figure 32 Market for Viral Load Tests in Europe to Register the Highest Growth During the Forecast Period
Figure 33 China Dominated the Asian HIV Diagnosis Market in 2016
Figure 34 Asia: HIV Diagnosis Market Snapshot
Figure 35 Antibody Tests Accounted for the Largest Share of the Asian HIV Diagnosis Market in 2016
Figure 36 Antibody Tests Accounted for the Largest Share of the HIV Diagnosis Market in China in 2016
Figure 37 Antibody Tests Held the Largest Share of the Japanese HIV Diagnosis Market in 2016
Figure 38 Antibody Tests Accounted for the Largest Share of the Indian HIV Diagnosis Market in 2016
Figure 39 Antibody Tests Held the Largest Share of the RoA HIV Diagnosis Market in 2016
Figure 40 Antibody Tests Held the Largest Share of the RoW HIV Diagnosis Market in 2016
Figure 41 Product Launch Was the Key Strategy Adopted By Players in the HIV Diagnosis Market
Figure 42 HIV Diagnosis Market Share Analysis, By Key Player, 2015
Figure 43 Geographic Revenue Mix of the Top Six Market Players
Figure 44 Siemens AG: Company Snapshot (2016)
Figure 45 Roche Diagnostics: Company Snapshot (2015)
Figure 46 Abbott Laboratories: Company Snapshot (2015)
Figure 47 Danaher Corporation: Company Snapshot (2015)
Figure 48 Thermo-Fisher Scientific Inc.: Company Snapshot (2015)
Figure 49 Merck KGaA: Company Snapshot (2015)
Figure 50 Becton, Dickinson & Company.: Company Snapshot (2016)
Figure 51 Hologic Inc.: Company Snapshot (2016)
Figure 52 Alere Inc: Company Snapshot (2016)
Figure 53 Bio-Rad Laboratories: Company Snapshot (2015)

  • Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
    Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309
    “Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......
  • Global Pharmaceutical Testing Services Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102
    Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......
  • Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......
  • Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......
  • Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......
  • Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......
  • Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151
    According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......
  • Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......
  • IVD Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs